CD8A and cancer: Interaction of PD-1, expressed on the surface of activated T-cells, B-cells, and macrophages, and PD-L1, expressed on immune and cancer cells can suppress the activity of CD8+ T-cell mediated immune response, and have therefore received attention for immunotherapy [26,27].